Life expectancy in the general population has improved progressively and the importance of agerelated macular degeneration in ophthalmology has increased proportionally. [1] [2] [3] [4] Subretinal neovascularization (SRN) may be caused by pathologic myopia and trauma in the younger population. Choroidal neovascular membrane, characterized by subretinal growth of choriocapillary endothelial cells, is the common determinant in these disorders.
INTRODUCTION
The similarity of choroidal neovascularization to tumors has led researchers to anticancer therapy modalities. Immunotoxins are being used widely against various tumors, and have also been shown to have a significant inhibitory effect against choroidal neovascularization. 12, 13 Immunotoxins are chimeric molecules in which toxins are conjugated to carriers. The carriers bind to specific receptors, and the toxins in the conjugate destroy the particular cell. 14, 15 Conjugates of the carrier basic fibroblast growth factor (bFGF) and toxin saporin act specifically on bFGF receptors that exist in choroidal neovascular membranes, resulting in high selectivity and relatively low retinal toxicity. [16] [17] [18] With this background, we used bovine choriocapillary endothelial cells (BCECs) to study the effect of bFGF-SAP on in vitro neovascularization.
MATERIALS AND METHODS

Culture of bovine choriocapillary endothelial cells (BCECs)
BCECs and recombinant bFGF-SAP conjugate were kindly provided by Dr. Stephen J. Ryan at Doheny Eye Institute. BCECs were cultured in Dulbecco's Modified Eagle's Medium (DMEM: Gibco) supplemented with 10% fetal bovine serum (FBS: Gibco, MD, USA). BCECs were confirmed to be vascular endothelial cells by positive immunostaining for von Willebrand factor (Santa Cruz Biotechnology, CA, USA) and binding of di1-acetylated-low density lipoprotein (LDL). 19 Fourth to seventh passaged cell were used.
Cell proliferation assay
BCECs (2 × 10 4 ) were seeded on 6-well culture plates and incubated for 24 hours in DMEM supplemented with 10% FBS until a confluency of 70-80% was observed. Various concentrations of bFGF-SAP (0.01, 0.1, 1, 10, 100 nM), an equimolar concentration of bFGF (R&D Systems Inc, MN, USA) or an equimolar concentration of saporin (Sigma, MO, USA) were then added and the mixture was further cultured for 72 hours. Viable cell numbers were finally counted by trypan blue exclusion. Every experiment was done in triplicate and repeated 3 times.
MTS assay
BCEC suspensions were seeded (5 × 10 3 cells/well) on 96-well culture plates, and then each well was further filled to a volume of 100 µl with 10% FBS supplemented with DMEM. The cells were incubated for 24-48 hours until a confluency of 70-80% was observed. Various concentrations of bFGF-SAP (0.01, 0.1, 1, 10, 100 nM), an equimolar concentration of bFGF (R&D Systems Inc, MN, USA) or an equimolar concentration of saporin (Sigma, MO, USA) were then added and the mixture was further incubated for 72 hours. Cell Titer 96 Aqueous 1 solution (Promega, WI, USA) was added (20 µl/well) at 37°C for 2-4 hours. Absorption at 490 nm was measured in a 96-well plate reader. Every experiment was done in triplicate and repeated 3 times.
The effect of serum bFGF on bFGF-SAP was also evaluated by MTS assay. Cells showing a confluency of 70-80% were incubated under FBS free and 10% FBS conditions, and then various concentrations of bFGF-SAP (0.01, 0.1, 1, 10, 100 nM) were added. MTS assay was done as described above.
Every experiment was done in triplicate and repeated 3 times.
Identification of apoptosis by TUNEL fluorostaining
BCECs (2 × 10 4 ) were seeded on 6-well culture plates and incubated for 24 hours in DMEM supplemented with 10% FBS until a confluency of 70 -80% was observed. Then 10 nM bFGF-SAP was added before further incubation for 72 hours. TUNEL fluorostaining was performed using the ApopTag Fluorescein Kit (Intergen, NY, USA) as described in the user's manual. Briefly, cells were dried at room temperature and then fixed with 4% paraformaldehyde solution (4% in phosphate buffered saline: PBS, pH 7.4) at room temperature for 10 minutes. After washing with PBS, the samples were left in ice (4°C) for 2 minutes with permeabilization solution (0.1% Triton X-100, 0.1% sodium citrate). The samples were dried and 50 µl of TUNEL reaction mixture was added before reaction proceeded at 37°C for 1 hour in a humidified chamber. Photographs were taken after washing 3 times with PBS.
Cell migration assay
BCECs (5 × 10 5 ) were seeded on 35 mm dishes and incubated until confluence. A spatula was used to denude half the area of each dish, and the margin was marked under each dish. Various concentrations of bFGF-SAP (1, 10, 100 nM) were added and incubated for 72 hours. Microphotographs were taken with an Axiovert S100 phase contrast microscope (Carl Zeiss, NY, USA).
Photoshop V6.0 was used to open the micrographs, and migration assay was performed using a method derived from a technique reported by Lehr et al. 20 A premarked margin was used as a reference line, and the area in which cells were present was selected. The dimension of this area was measured using the Histogram function of Photoshop. The total area of the whole photograph was also taken as a reference and the relative migration area was calculated as the percentage ratio of the cellular area to this reference value. Percentage migration was quantified by calculating the ratio of the experimental migration area to the control migration area.
Microtubule formation assay
Three-dimension collagen gel mixture [7 volumes of rat tail type I collagen (Roche, Germany), 2 volumes of 5 times concentrated DMEM and 1 volume of 200 mM HEPES (Gibco); pH fixed at 7.0 with 1 N NaOH] was added to 24-well plates (0.4 ml/well) and incubated at 37°C for 3 hours. After polymerization of the gels, BCECs (2 × 10 4 ) were seeded on each gel and incubated until a confluency of about 70-80% was observed. Various concentrations of bFGF-SAP (1, 10, 100 nM) were added and incubated for 24 hours. Microphotographs of the tubulelike formations were taken with a phase contrast microscope. Modified image analysis methods used in the evaluation of tubules were applied. [21] [22] [23] Photoshop was used to calculate the total dimension of the tubule-like structures as in the previous migration assay. Microtubule formation was quantified by calculating the percentage ratio of the experimental tubule formation area to the control tubule formation area.
Statistical analysis
Paired two-tailed t test (Sigmaplot, SPSS Inc., IL, USA) was used to statistically analyze the differences between the experimental and control groups. Nonlinear regression (SPSS, SPSS Inc.) was used to analyze cell proliferation and MTS assay.
RESULTS
The effect of bFGF-SAP on BCEC proliferation
The bFGF-SAP conjugate inhibited the cellular proliferation of BCEC in a dose-dependent manner. Nonlinear regression revealed a typical reverse S standard curve of inhibition. The ID 50 was 0.62 nM ( Fig. 1-A) .
In contrast, bFGF alone stimulated cell proliferation (P < 0.01). At low concentration saporin had no significant effect (P = 0.58 at 0.05 nM), but showed significant inhibition at high concentration (P < 0.01 at 50 nM) ( Fig. 1-B) .
MTS assay
The bFGF-SAP conjugate inhibited the proliferation and metabolism of BCEC in a dose-dependent manner. Nonlinear regression revealed a typical reverse S standard curve of inhibition ( Fig. 2-A) . The ID 50 was 0.75 nM (Fig. 2-A) .
In contrast, bFGF alone stimulated proliferation and metabolism (P < 0.01) at higher concentrations. Saporin showed significant inhibition at high concentration (P < 0.01 at 50 nM) ( Fig. 2-B) . Meanwhile, bFGF-SAP showed significantly higher inhibition in the FBS-free group compared to the 10% FBS group. However, both groups showed dose-dependent inhibition (Fig. 3) .
Apoptosis identification by TUNEL assay
Apoptosis was confirmed by TUNEL assay with the appearance of positive bright green fluorescence corresponding to DNA fragments (Fig. 4) . 
Migration assay
The cellular area of the control group (bFGF-SAP free) was 85.48 ± 2.74%, and that with bFGF-SAP at 1, 10, and 100 nM was 73.66 ± 4.09, 61.68 ± 5.07 and 56.21 ± 4.79%, respectively. This corresponds to a significant dose-dependent inhibition of 13.8, 27.7 and 34.3% with bFGF-SAP at 1, 10 and 100 nM, respectively (P < 0.01) (Figs.  5, 6 ).
Microtubule formation assay
The control group (bFGF-SAP free) showed microtubule formation of 27.75 ± 3.37%. Microtubule formation of 24.46 ± 2.18, 10.38 ± 0.84 and 5.15 ± 0.56% was observed with bFGF-SAP at 1, 10, and 100 nM, respectively.
The bFGF-SAP conjugate at 1 nM inhibited microtubule formation by 11.85%, but was not significant. At 10 and 100 nM, significant inhibition of 62.58 and 81.42% was observed (P < 0.01) (Figs. 7,  8) 
DISCUSSION
Choriocapillary neovascularization into the subretinal space, or SRN, is one of the most important causes of visual loss, and the main lesion in exudative age related macular degeneration (ARMD). It can also develop in pathologic myopia and after trauma. [24] [25] [26] [27] The ideal treatment modality requires a complete destruction of the preformed neovascular membranes and prevention of its recurrence. Unfortunately, no definite treatment has been reported so far.
Direct excision of the neovascular membrane and radiologic therapies have been tried, but complica- Fig. 4 . Effect of serum on bFGF-SAP-induced inhibition of bovine choriocapillary endothelial cells. In comparison to the 10% FBS group, cell proliferation was decreased in the serum-free group at a given concentration of bFGF-SAP, but still showed a dosedependent inhibition. The effect of serum was significant. Results are given as a mean S.D. * P < 0.01 compared between serum-free and 10% FBS at a given concentration of bFGF-SAP. 
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tions are severe and their efficacy remains questionable. [28] [29] [30] [31] Direct photoablation using laser is accepted as the most efficient treatment, 5 but its own complications and limitation of application impose a strict limit to cases that can be treated.
Preventive methods based on environmental and nutritional factors related to the development of SRN are under investigation, [6] [7] [8] but agents that act directly on preformed neovascular membranes have not yet been reported. At present, medicine is being used indirectly in the form of adjuvants in dye laser photoablation. [9] [10] [11] SRN is similar to tumors due to its high rate of recurrence and rich vascularity. In this context, the application of antitumor agents is feasible. Several treatment modalities exist for the control of tumors, and with its emphasis on safety, efficacy and availability, the widely used immunotoxin has been considered to be the best candidate. 12, 13, [32] [33] [34] [35] [36] [37] Immunotoxins are chimeric molecules in which toxins derived from bacteria and plants are conjugated to carriers such as antibodies, hormones, and growth hormones. The carriers facilitate transport of the toxins, and also enhance efficacy and reduce adverse effects by binding to specific receptors. After binding to these receptors, the toxins in the conjugate destroy the particular cell. 15 At present immunotoxins are being used in various forms, and results are being continuously published. As with other treatment modalities, complications have also been reported. [38] [39] [40] However, these have appeared under systemic application, whereas local application would suffice in SRN. Clinical application would be easier.
In the field of ophthalmology, immunotoxins have been mostly studied for preventing the development of posterior capsular opacity in aftercataract. [41] [42] [43] Studies involving neovascularization have usually used vessels that can be easily obtained. Although it is helpful in studying the pathogenesis or pathology of neovascularization, there is the problem of endothelial cells in different tissues showing complete phenotypic and antigenic heterogeneity. [44] [45] [46] [47] [48] This could lead to completely different results from similar experiments. In this respect Hoffmann et al have firmly suggested using choroidal endothelial cells in the study of choroidal diseases. 48 It has been reported that bFGF is a potent mitogen and chemoattractant of various cells, and stimulates microtubule formation of endothelial cells in three-dimension collagen gel. 49, 50 Saporin is a type I ribosome inactivating protein extracted from the seeds of Saponaria officinalis that induces apoptosis by hydrolyzing rRNA. 15, 40, 51 It is composed of a single chain so its internalization is limited, but at high concentrations (10 -8 -10 -6 M) it shows some toxicity. [51] [52] [53] Highly resistant to degeneration and hydrolyzation, it can safely be conjugated to other carriers, facilitating its application.
The bFGF-SAP chimera is a conjugate of the carrier bFGF and the toxin saporin. It is highly specific to bFGF receptors and is also a potent competitor of bFGF. Apoptosis is responsible for cytotoxicity, thereby enabling the destruction of the pathologic tissue with minimal damage to adjacent normal tissues. At its effective inhibitory dose, it exerts minimal toxicity to normal tissues that do not express bFGF receptors.
A large number of bFGF receptors exist in choroidal neovascular membranes, so the bFGF-SAP conjugate acts specifically on these receptors, resulting in high selectivity and relatively low retinal toxicity. 13, 54 The cytotoxicity of bFGF-SAP was dose-dependent and its ID 50 was 0.62 nM. The ability of bFGF alone to stimulate proliferation confirmed the existence of bFGF in BCEC. Single use of saporin showed significant inhibition only at high concentrations (50 nM). This agrees with other studies in which saporin alone was used, as internalization of the toxin is difficult.
MTS assay also showed a dose-dependent inhibition (ID 50 = 0.75). Serum decreased the inhibitory effect of bFGF-SAP. Growth factors other than bFGF could have been responsible for this effect, but as bFGF-SAP acts specifically on bFGF receptors, it is highly probable that this inhibition results from competition with bFGF in the serum. 16 Regardless of the presence of serum, bFGF-SAP showed consistent dose-dependent inhibition.
The cytotoxicity of saporin is reported to be caused by apoptosis, 55 and this was confirmed by TUNEL assay.
Migration assay of endothelial cells requires a specific angiogenic factor, but BCECs exert contact inhibition resulting in spontaneous migration. 56 As no physical barrier was used, migration was dosedependently inhibited through bFGF-SAP. In this study we evaluated migration inhibition using a modified technique with photographs and a graphics program (Photoshop). 20, 57 In contrast to other cultures, BCECs require a three-dimensional gel to form tubule-like structures. As with migration, tubule formation is spontaneous when a three-dimensional gel is used. 56, 58 This may be the reason that some have reported contradictory results with similar experiments using different endothelial cells. We used an appropriate gel matrix, so the results were satisfactory and inhibition could be identified.
Image analysis programs or graphics programs such as Photoshop are widely used in the analyses of tubule-like structures. [20] [21] [22] [23] The same technique as in the migration assay was used to evaluate the inhibition of tubule formation. Tubule formation was also inhibited in a dose-dependent manner.
Studies have revealed that SRN requires endothelial cell proliferation, migration and differentiation. In this experiment we confirmed that bFGF-SAP inhibits all these aspects responsible for the development of choriocapillary neovascularization.
In conclusion, bFGF-SAP is highly specific to bFGF receptors and is a potent competitor to bFGF. Apoptosis is responsible for the cytotoxicity, thereby enabling the destruction of the pathologic tissue with minimal damage to adjacent normal tissues. As previously mentioned, saporin is very stable, so carriers in the immunotoxin can be easily modified. This means that various receptors responsible for the development and growth of SRN can be targeted. As ARMD is suspected to have a multifactorial cause, various receptors may have to be simultaneously blocked. At present, VEFG and hGF (scatter factor) look very promising. A cocktail therapy with various carriers and saporin could be very effective.
Allowing these considerations, at this stage the true role of bFGF-SAP alone in the actual management of SRN has not yet been substantiated. However, we have confirmed that it plays an important background role in immunotoxin-related treatment modalities.
